Company / Assets per Share
Kura Oncology, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.44
FY2025
5-year range
$6.13 / $10.22
FY2021-FY2025
Trend
-7.7%
vs FY2024
Sector context
#102 of 210
Health Care
What the data says
At $9.44, Kura Oncology, Inc.'s assets per share ranks #102 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $3.73 in FY2016 to $12.19 in FY2020.
Based on SEC 10-K filings.
9.44 in FY2025 with a 5-year CAGR of -5.0%.
Improved from $6.13 to $9.44 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +11.5%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Sector benchmark
#102 of 210 in Health CareTop 49% of 210This company $9.44 Sector average $353.15
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 7.7% year-over-year.
- Ranks #102 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.44 | -7.7% |
| FY2024 | $10.22 | +66.8% |
| FY2023 | $6.13 | -10.0% |
| FY2022 | $6.81 | -15.4% |
| FY2021 | $8.05 | -34.0% |
| FY2020 | $12.19 | +111.4% |
| FY2019 | $5.77 | +11.3% |
| FY2018 | $5.18 | +25.6% |
| FY2017 | $4.12 | +10.5% |
| FY2016 | $3.73 | -57.5% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026